Literature DB >> 20580908

Inhibitory influence of mecamylamine on the development and the expression of ethanol-induced locomotor sensitization in mice.

Pravinkumar S Bhutada1, Yogita R Mundhada, Kuldeep U Bansod, Pankaj V Dixit, Sudhir N Umathe, Dharmendra R Mundhada.   

Abstract

Several evidences have indicated the involvement of neuronal nicotinic acetylcholine receptors (nAChR) in behavioral effects of drugs of abuse, including ethanol. nAChRs are implicated in ethanol-induced behaviors as well as neurochemical responses to ethanol. Recently, it is demonstrated that mecamylamine, a nAChR antagonist blocks cocaine-, d-amphetamine-, ephedrine-, nicotine-, and methylphenidate-induced psychomotor sensitization. However, no reports are available on its role in ethanol-induced psychomotor sensitization. Therefore, an attempt was made to evaluate its effect on ethanol-induced locomotor sensitization using a model previously described by us. The results revealed that acute administration of mecamylamine (1 and 2mg/kg, i.p.) blocked the acute stimulant effect of ethanol (2.0g/kg, i.p.). In addition, treatment with mecamylamine (0.5-2.0mg/kg, i.p.), 30min prior to the challenge dose of ethanol (2.0g/kg, i.p.) dose dependently attenuated expression of sensitization to locomotor stimulant effect of ethanol. Moreover, administration of mecamylamine (1 and 2mg/kg, i.p.) during development (prior to each ethanol injection on days 1, 4, 7, and 10) blocked acquisition as well as expression (day 15) of sensitization to locomotor stimulant effect of ethanol. Mecamylamine per se did not affect locomotor activity. Further, it also did not influence blood ethanol levels and rotarod performance in mice. These results support the hypothesis that neuroadaptive changes in nAChRs may participate in the development and the expression of ethanol-induced locomotor sensitization. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580908     DOI: 10.1016/j.pbb.2010.05.015

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation.

Authors:  Helen M Kamens; Nicole R Hoft; Ryan J Cox; Jill H Miyamoto; Marissa A Ehringer
Journal:  Alcohol       Date:  2012-05-07       Impact factor: 2.405

3.  Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.

Authors:  T Bordia; M McGregor; J M McIntosh; R M Drenan; M Quik
Journal:  Neuroscience       Date:  2015-03-24       Impact factor: 3.590

4.  Effects of nicotine on ethanol-induced locomotor sensitization: A model of neuroadaptation.

Authors:  Noah R Gubner; Tamara J Phillips
Journal:  Behav Brain Res       Date:  2015-04-06       Impact factor: 3.332

Review 5.  The role of nicotinic acetylcholine receptors in alcohol-related behaviors.

Authors:  C N Miller; H M Kamens
Journal:  Brain Res Bull       Date:  2020-07-22       Impact factor: 4.077

Review 6.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

7.  Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization.

Authors:  Lauren C Kruse; David N Linsenbardt; Stephen L Boehm
Journal:  Alcohol       Date:  2012-05-02       Impact factor: 2.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.